A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity (Q665054)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity |
scientific article; zbMATH DE number 6011877
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity |
scientific article; zbMATH DE number 6011877 |
Statements
A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity (English)
0 references
5 March 2012
0 references
Bayesian design
0 references
treatment selection
0 references
0 references
0 references
